Aldolases, nucleic acids encoding them and methods for making and using them
View Patent ↗This invention relates to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In some embodiments, the invention is directed to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides in accordance with the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts. In some embodiments, the invention provides polypeptides and biosynthetic pathways that are useful in the production of R-2-hydroxy 2-(indol-3ylmethyl)-4-keto glutaric acid (R-MP) and certain stereoisomers of monatin, such as R,R and S,R monatin, and salts thereof, as well as certain stereoisomers of monatin derivatives, such as the R,R and S,R configurations, and salts thereof.
1. An isolated, synthetic, or recombinant polypeptide or peptide having an aldolase activity comprising
(a) an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or more, or 100% sequence identity to the full length of SEQ ID NO:276; or,
(b) an amino acid sequence encoded by a nucleic acid sequence having the full length of SEQ ID NO:275.
2. The isolated, synthetic, or recombinant polypeptide of claim 1 wherein the polypeptide comprises at least one glycosylation site or further comprises a polysaccharide.
3. A protein preparation comprising the polypeptide of claim 1 , wherein the protein preparation comprises a liquid, a solid, or a gel.
4. A heterodimer or a homodimer comprising the polypeptide of claim 1 .
5. A method for utilizing an aldolase of claim 1 as a supplement in an animal diet, the method comprising: preparing a supplement containing an aldoase enzyme comprising the polypeptide of claim 1 ; and administering the supplement to an animal.
6. A composition comprising the polypeptide of claim 1 .
7. The polypeptide of claim 1 , but lacking a signal sequence.
8. The potypeptide of claim 1 , further comprising a heterologous sequence; wherein the heterologous sequence comprises one or more of: a tag an epitope, a targeting peptide, a cleavable sequence, a detectable moiety, or a polypeptide that does not have aldolase activity.
9. The polypeptide of claim 1 , wherein, the aldolase activity comprises a pyruvate, HMG, or KHG aldolase activity.
10. The polypeptide of claim 1 , wherein the amino acid sequence is a fragment of the full length of SEQ ID NO:276 and the fragment has aldolase activity.
11. An isolated, synthetic, or recombinant polypeptide or peptide having an aldolase activity comprising an amino acid sequence that is at least 95% identical to the full length of SEQ ID NO:276.
12. An isolated, synthetic, or recombinant polypeptide comprising an amino acid sequence that is SEQ ID NO:276.